Cargando…
Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel/apatinib effectively reverse cancer multidrug resistance
Multidrug resistance (MDR) of cancer cells is a significant challenge in chemotherapy, highlighting the urgent medical need for simple and reproducible strategies to reverse this process. Here, we report the development of an active tumor-targeting and redox-responsive nanoplatform (PA-ss-NP) using...
Autores principales: | Zhang, Xiaoqing, Ren, Xiaomei, Tang, Jiayin, Wang, Jiangtao, Zhang, Xiang, He, Peng, Yao, Chang, Bian, Weihe, Sun, Lizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216478/ https://www.ncbi.nlm.nih.gov/pubmed/32489129 http://dx.doi.org/10.1080/10717544.2020.1770373 |
Ejemplares similares
-
Dual functionalized hyaluronic acid micelles loading paclitaxel for the therapy of breast cancer
por: Liu, Zhanbiao, et al.
Publicado: (2023) -
Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo
por: Wang, Jinling, et al.
Publicado: (2018) -
Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel
por: Zhang, Xiaomin, et al.
Publicado: (2017) -
Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance
por: Dong, Kai, et al.
Publicado: (2016) -
Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance
por: Wang, Shuanghu, et al.
Publicado: (2017)